Molecular Monitoring of Response to Imatinib (Glivec) in Chronic Myeloid Leukemia Patients: Experience at a Tertiary Care Hospital in Saudi Arabia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular Monitoring of Response to Imatinib (Glivec) in Chronic Myeloid Leukemia Patients: Experience at a Tertiary Care Hospital in Saudi Arabia

Published:2010-02 Issue:1 Volume:14 Page:67-74
ISSN:1945-0265
Container-title:Genetic Testing and Molecular Biomarkers
language:en
Short-container-title:Genetic Testing and Molecular Biomarkers

Author:

Khalil Salem H.¹,Abu-Amero Khaled K.²³,Mohareb Fahad Al⁴,Chaudhri Naeem A.⁴

Affiliation:

1. Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

2. Department of Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

3. Molecular Genetics Laboratory, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

4. Oncology Cancer Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

Publisher

Mary Ann Liebert Inc

Subject

Genetics(clinical),General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/gtmb.2009.0126

Reference41 articles.

1. Roots of Clinical Resistance to STI-571 Cancer Therapy

2. Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations

3. Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alternative Animal Toxicity Testing and Biomarkers;Biomarkers in Toxicology;2019

2. Modelling Predictors of Molecular Response to Frontline Imatinib for Patients with Chronic Myeloid Leukaemia;PLOS ONE;2017-01-03

3. Molecular Monitoring of patients with Chronic Myeloid Leukemia (CML) in the state of Qatar: Optimization of Techniques and Response to Imatinib;QScience Connect;2014-03-01

4. Alternative animal toxicity testing and biomarkers;Biomarkers in Toxicology;2014

5. Correction;Genetic Testing and Molecular Biomarkers;2010-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3